Literature DB >> 2918162

Relation between exertional ischemia and prognosis in mildly symptomatic patients with single or double vessel coronary artery disease and left ventricular dysfunction at rest.

G Mazzotta1, R O Bonow, L Pace, E Brittain, S E Epstein.   

Abstract

The randomized multicenter trials indicate that survival in patients with coronary artery disease and left ventricular dysfunction is enhanced by surgical therapy compared with medical therapy. This beneficial effect of coronary bypass surgery was demonstrated in patients with either three vessel or left main coronary artery disease, but not in those with one or two vessel disease. To determine whether subgroups of mildly symptomatic patients with one or two vessel coronary artery disease and left ventricular dysfunction have an increased risk of death or cardiac events during medical therapy, 53 consecutive patients with angiographically defined one or two vessel disease and impaired left ventricular function (ejection fraction 20% to 40%) were studied by exercise electrocardiography (ECG) and rest and exercise radionuclide angiography. All but two patients had previous myocardial infarction, and all were asymptomatic or only mildly symptomatic during medical therapy. By univariate life table analysis, mortality during medical therapy was associated significantly with the ST segment response to exercise (p less than 0.05) and with both the exercise ejection fraction (p less than 0.05) and the magnitude of change in ejection fraction with exercise (p less than 0.005). In patients with an exercise ejection fraction greater than 30%, the probability of survival at 6 years was 97 +/- 3% (+/- SE) compared with a survival rate of 62 +/- 14% in the remaining subjects (p less than 0.005). Similarly, 6 year survival was 100% in patients whose ejection fraction increased from the value at rest but was only 74 +/- 10% in the remaining patients (p less than 0.005). Exercise capacity was not associated with survival.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2918162     DOI: 10.1016/0735-1097(89)90594-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

1.  Does exercise radionuclide angiography still have a role in clinical cardiac assessment?

Authors:  A D Kelion; A P Banning; O J Ormerod
Journal:  J Nucl Cardiol       Date:  1999 Sep-Oct       Impact factor: 5.952

Review 2.  Stress echocardiography in the diagnosis of coronary artery disease.

Authors:  W Mazur; S F Nagueh
Journal:  Curr Atheroscler Rep       Date:  2001-03       Impact factor: 5.113

Review 3.  Role of nuclear cardiology for determining management of patients with stable coronary artery disease.

Authors:  R J Gibbons
Journal:  J Nucl Cardiol       Date:  1994 Sep-Oct       Impact factor: 5.952

Review 4.  Prognostic assessment in coronary artery disease: role of radionuclide angiography.

Authors:  R O Bonow
Journal:  J Nucl Cardiol       Date:  1994 May-Jun       Impact factor: 5.952

5.  Risk stratification of patients with coronary artery disease and left ventricular dysfunction by exercise radionuclide angiography and exercise electrocardiography.

Authors:  G Mazzotta; L Pace; R O Bonow
Journal:  J Nucl Cardiol       Date:  1994 Nov-Dec       Impact factor: 5.952

6.  The differing prognostic utility of exercise radionuclide ventriculography in coronary artery disease patients with and without prior myocardial infarction.

Authors:  M Moriel; A Rozanski; J Klein; D S Berman; C N Merz
Journal:  Int J Card Imaging       Date:  1997-10

Review 7.  Assessment of left ventricular dysfunction by nuclear cardiology.

Authors:  J A Melin; W Wijns; J L Vanoverschelde; G R Heyndrickx
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.